Riskpilot← Back to searchSign inGet full accessAptevoke AB
ABActiveOrg 5591468433Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20180 employees
Revenue 2025
—
EBITDA margin
—
-85% vs 2024
Equity ratio
83.4%
Financial strength
Net profit 2025
SEK -8K
-80% vs 2024
| Revenue | — | — |
| EBITDA | SEK -8K | -85% |
| Net profit | SEK -8K | -80% |
| Total assets | SEK 24K | -26% |
| Equity | SEK 20K | -28% |
| Employees | 0 | — |
Legal name
Aptevoke AB
Org number
5591468433
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
26 januari 2018
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-09-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
partihandel av alla typer av utsäde (fröer), bekämpningsmedel (pesticid) och gödningsmedel
Address
Email
edris.safavi@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 83 | 0 | 0 | — | — |
| Staff expenses | — | — | — | — | — |
| EBITDA | −5 | −8 | −3 | −5 | −8 |
| Depreciation & amort. | −0 | −0 | −0 | — | — |
| EBIT | −5 | −8 | −3 | −5 | −8 |
| Net financials | — | — | — | 0 | 0 |
| Profit before tax | −5 | −8 | −3 | −4 | −8 |
| Tax | −0 | −0 | −0 | — | 1 |
| Net profit | −5 | −8 | −3 | −4 | −8 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 62 | 53 | 52 | 33 | 24 |
| Equity | 44 | 35 | 32 | 28 | 20 |
| Long-term debt | 0 | 0 | 0 | — | — |
| Short-term debt | 18 | 18 | 20 | 5 | 4 |
| Total debt | 18 | 18 | 20 | 5 | 4 |
EBITDA margin
-836300.0%
This company
15.8%
Market median
-5293138% vs market
20212025
Equity ratio
83.4%
This company
38.2%
Market median
+118% vs market
20212025
Return on equity
-38.8%
This company
18.4%
Market median
-311% vs market
20212025
Net profit margin
-779300.0%
This company
8.1%
Market median
-9621088% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.20×
This company
0.62×
Market median
+68% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-12-01 – 2025-09-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-12-01 – 2024-11-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-12-01 – 2023-11-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-12-01 – 2022-11-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-12-01 – 2021-11-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2025 | |
| Board of Directors | 2022 | |
| Former (6) | ||
| Board of Directors | 2022 – 2025 | |
| Board of Directors | 2022 – 2025 | |
| Deputy Board Member | 2022 – 2025 | |
| Deputy Board Member | 2022 – 2025 | |
| Deputy Board Member | 2022 – 2025 | |
| Board of Directors | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Aptevoke AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hossein Dadfar | Board of Directors | 0 companies |
| Majid Safavi | Deputy Board Member | 0 companies |
| Alan Kambiz Fotoohi | Board of Directors | 0 companies |
| Ibrahim Taher Ibrahim El Serafi | Deputy Board Member | 0 companies |
| Nasrin Hosseini | Deputy Board Member | 0 companies |
| Aida Vahdat Shariat Panahi | Deputy Board Member | 0 companies |
| Mojtaba Hosseini | Board of Directors | 0 companies |
| Edris Safavi | Board of Directors | 0 companies |